Media-OutReach Newswire CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Media-OutReach Newswire HKU’s innovative research novelties excel at 48th International Exhibition of Inventions of Geneva
Media-OutReach Newswire The Malaysia Healthcare Travel Council: Upholding Medical Innovations as a Cancer Care Centre of Excellence
Media-OutReach Newswire HKBU joint research develops multifunctional nanoparticle for diagnosis and treatment of glioma
Media-OutReach Newswire Betters Medical Investment Holdings Limited to raise a maximum of approximately HK$427 million by way of Global Offering
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.